Vinta Bio is a Cell and Gene Therapy CDMO (Contract Development and Manufacturing Organization) nestled in the historic Navy Yards of Philadelphia, PA
Who we are
Our founders are recognized leaders in Cell and Gene Therapy. We have unmet experience in pioneering the early viral vectors of two FDA-approved AAV gene therapy products, Luxturna® and Zolgensma®. Our executive team also played critical roles in the CMC filing for Luxturna®.
Our founders and team have over Ninety Years of combined Cell and Gene Therapy Experience and have overcome many of the same hurdles you currently may be facing with your viral vector production: Everything from proof-of-concept to clinical trials and Biologics License Applications. We understand the gravity of the decision to outsource your clinical programs and are eager to show you why Vinta Bio can be your trusted partner in reaching your program’s next milestone!
What we do
Vinta Bio provides Cell and Gene Therapy manufacturing services to pharmaceutical, biotechnology, academic and government organizations that are developing drugs for use in clinical trials. Vinta Bio has experienced staff to drive efficiency and produce high quality cGMP grade viral vectors and research grade vectors via partnership with our sister company SAB Tech, Inc. Current vector capabilities include, but are not limited to, Adeno-associated virus (AAV) and Lentiviral vectors (LVV).
Research Vector Service, via our partners at SAB Tech, Inc.
Research grade Plasmid Manufacturing
Process Development and Optimization
Analytical Methods Development and Optimization
Clinical Testing Support
cGMP Production and non-GMP Production
CMC and Regulatory Support
Eager to learn more about partnering with Vinta Bio? Give us a call so we can discuss your program reach the next milestone!